Potential association between elevated serum human epididymis protein 4 and chronic kidney disease in female patients

摘要

Serum levels of human epididymis protein 4 (HE4) are elevated in a large number of women with chronic kidney disease (CKD). However, it remains unclear whether HE4 can be used as a potential biomarker for the diagnosis of CKD. This study aims to determine whether serum HE4 is a potential biomarker for CKD in Han Chinese female patients. A total of 347 Han Chinese female patients aged 19 to 89 were included in the present study. Among these patients, 154 were healthy control individuals, while 193 were hospitalized patients with CKD. Their demographic characteristics were obtained, and the levels of serum creatinine (Scr), beta2-microglobulin (B2M), and cystatin C (CysC) (to assess renal function) were measured. Serum HE4 concentration was determined by electrochemiluminescence. Serum HE4 levels in patients with CKD were significantly higher than those in the control group (P < 0.001). Meanwhile, there were significant differences in HE4 levels among the four CKD subgroups (P < 0.001) via multiple comparisons. In addition, the diagnostic value of HE4 was significantly higher than other indicators by ROC curve analysis. HE4 may not only serve as a potential biomarker to predict CKD but also have an important reference value for CKD staging.